by University of Sussex Scientists at the University of Sussex have identified a potential pattern within blood which signals the presence of motor neuron disease; a discovery which could significantly improve diagnosis. Currently, it can take up to a year for a patient to be diagnosed with amyotrophic lateral sclerosis(ALS), more commonly known as motor...
By JULIET ISSELBACHERJUNE 18, 2020 New research untangles the complex code the brain uses to distinguish between a vast array of smells, offering a scientific explanation for how it separates baby powder from bleach, lemon from orange, or freshly cut grass from freshly brewed coffee. A single scent can trigger a complex chain of events...
Chemical found in apple peel could transform multiple sclerosis treatment Compound could be turned into the first drug that reverses disease’s damage Testing on mice, paralysed animals given ursolic acid were able to walk again A chemical in apple peel could transform the treatment of multiple sclerosis, research reveals. The compound that gives apple skin...
By Nick Lavars June 09, 2020 It is well known that consuming food and drink high in sugar is not great for us, but scientists are continuing to unravel the intricacies of how the sweet stuff drives negative health outcomes. The latest finding comes from researchers at the University of Michigan, who through studies in...
Like any addiction, nicotine dependence warps the brain in elaborate ways—which is why treating it tends not to be as simple as mastering one’s willpower. Even after trying every technique in the toolbox—the support of friends, family, and a great therapist; nicotine patches; prescription drugs—many smokers will sooner or later experience a craving of overpowering...
Automated 3D brain imaging data analysis technology offers more reliable and standardized analysis of the spatial organization of complex neural circuits.- THE KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KAIST) KAIST researchers developed a new algorithm for brain imaging data analysis that enables the precise and quantitative mapping of complex neural circuits onto a standardized...
SOUTH SAN FRANCISCO, Calif. – May 6, 2020 – Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel, disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheimer’s (AD) and other degenerative diseases, today announced the publication of research further documenting the ability of the pathogen...
By Nick Lavars While its exact causes are unknown, Alzheimer’s disease is commonly associated with clumps of toxic amyloid plaques in the brain, and researchers are continuing to understand the different components that help them take shape. Scientists at the University of Illinois at Urbana-Champaign have developed a new compound that attacks a number of...
by Baylor College of Medicine Low blood sugar levels, known as hypoglycemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high. Solutions to this problem may come from a better understanding of the basic mechanisms keeping blood sugar...
By: PROFESSOR SEUNG-HEE LEE, KAIST Researchers have confirmed that neuropeptide somatostatin can improve cognitive function in the brain. A research group of Professor Seung-Hee Lee from the Department of Biological Sciences at KAIST found that the application of neuropeptide somatostatin improves visual processing and cognitive behaviors by reducing excitatory inputs to parvalbumin-positive interneurons in the...
